Korio is a RTSM platform that provides solutions to tackle clinical trial challenges.
Korio has raised $5.5M in total funding. The most recent round was Series A. The last funding was announced in September 2024.
Korio's investors include BIP Ventures, Excelerate Health Ventures, Boston Millennia Partners.
Korio is headquartered in Doylestown, United States.
Korio is a RTSM platform that provides solutions to tackle clinical trial challenges.
Korio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Korio — Funding & Investors." VCBacked, September 10, 2024, https://www.vcbacked.co/company/korio. Accessed September 13, 2026.
VCBacked. (2024). Korio — Funding & Investors. Retrieved September 13, 2026, from https://www.vcbacked.co/company/korio
{{cite web |title=Korio — Funding & Investors |url=https://www.vcbacked.co/company/korio |website=VCBacked |access-date=September 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated